Development of the Oncology Opportunity Cost Assessment Tool
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04694911|
Recruitment Status : Recruiting
First Posted : January 5, 2021
Last Update Posted : January 5, 2021
|Condition or disease||Intervention/treatment|
|Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm||Behavioral: Focus Group Other: Interview Other: Research or Clinical Assessment Tool|
|Study Type :||Observational|
|Estimated Enrollment :||172 participants|
|Official Title:||Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)|
|Actual Study Start Date :||November 21, 2019|
|Estimated Primary Completion Date :||January 2021|
|Estimated Study Completion Date :||January 2021|
Health Services Research (focus group, interview, OOCAT)
FOCUS GROUP: Patients participate in focus group session over 60-90 minutes.
COGNITIVE INTERVIEW: Patients complete cognitive interview on the clarity, interpretability, and ease of use of the OOCAT.
FEASIBILITY TESTING: Patients receive OOCAT at the point of care, online, or via telephone, per patients' preference.
Behavioral: Focus Group
Participate in focus group
Complete cognitive interview
Other: Research or Clinical Assessment Tool
Other Name: Clinical Assessment Tool, Clinical Assessment Tool, Clinical or Research Assessment Tool
- Patient-level opportunity costs associated with oncology care [ Time Frame: 1 Day of Interview ]Patient-identified themes that contribute to opportunity cost will be generated via patient focus groups
- Development of the Oncology Opportunity Cost Assessment Tool (OOCAT) [ Time Frame: 1 Day of Interview ]Will organize themes into domains and will generate items representing each of the themes for inclusion in an instrument designed to measure patient opportunity cost of seeking care. Will perform cognitive interviews with a random sampling of patients from the cancer center to test initial instrument items to ensure content validity and clarity of each item.
- Implementation of OOCAT [ Time Frame: 1 Day of OOCAT administration ]Will test the instrument as developed with patients receiving oncology care across the Jefferson Health System to gather preliminary data informing the reliability of the scale to measure opportunity cost of seeking care.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04694911
|Contact: Nathan Handley, MD||215-955-8874||Nathan.Handley@jefferson.edu|
|United States, Pennsylvania|
|Sidney Kimmel Cancer Center at Thomas Jefferson University||Recruiting|
|Philadelphia, Pennsylvania, United States, 19107|
|Contact: Nathan Handley, MD 215-955-8874 Nathan.Handley@jefferson.edu|